12/29/05 VGX Announces Preliminary Results on the Phase I/II Clinical Trials of PICTOVIR™
12/22/05 VGX Pharmaceuticals Announces Research Collaboration with the University of Pennsylvania
9/26/05 VGX Pharmaceuticals Initiates the Phase II Clinical Trials of VGX - 410C for the Treatment of Chronic Hepatitis C Infection
8/21/05 VGX Announces FDA Acceptance of IND Application for VGX-410C
8/1/05 VGX announced key management team promotions and additions
7/21/05 Filing of IND Application for the treatment of Hepatitis C infection
5/1/05 VGX Pharmaceuticals Announces Relocation to New Corporate Headquarters
12/15/04 VGX Pharmaceuticals Initiates Phase I/II Clinical Trials of PICTOVIR™ for the Treatment of HIV Infection
12/1/04 VGX Pharmaceuticals Announces FDA Acceptance of IND Application for PICTOVIR™
11/1/04 VGX Pharmaceuticals Announces IND Submission for PICTOVIR™
12/27/04 NEWSWEEK Whoês Next 2005: The Pill Pusher
2/9/04 THE NEW YORKER: The Pipeline Problem
1/23/04 FORBES: Striving To Stop HIV
12/11/03 THE WORLD ECONOMIC FORUM ANNOUNCES TECHNOLOGY PIONEERS FOR 2004: The Next Big Thing?
12/11/03 THE WORLD ECONOMIC FORUM ANNOUNCES TECHNOLOGY PIONEERS FOR 2004
12/11/03 THE WORLD ECONOMIC FORUM DESIGNATES TECHNOLOGY PIONEERS FOR 2004: VGX PHARMACEUTICALS SELECTED
10/15/03 J. Joseph Kim named Among 50 Most Influential Men under 38
8/27/03 VGX Pharmaceuticals Receives A Second NIH Phase I SBIR Gran
5/15/03 VGX Pharmaceuticals Receives NIH Grant
12/15/02 VGX Pharmaceuticals Receives NIH Phase I SBIR Grant
9/16/02 VIRAL GENOMIX FEATURED IN PHILADELPHIA BUSINESS JOURNAL
9/10/02 VGX Pharmaceuticals Receives Key Patent For Cellular Receptor For HIV-1
5/23/02 J. JOSEPH KIM, Ph.D. NAMED ONE OF THE WORLD’S TOP YOUNG INNOVATORS BY TECHNOLOGY REVIEW, MIT’S MAGAZINE OF INNOVATION
5/16/02 THE KNOWLEDGE FOUNDATION - DR. KIM TO PRESENT AT THE TISSUE & GENETIC ENGINEERING FOR THE TREATMENT OF ARTHRITIC DISEASES
2/11/02 VGX'S J. JOSEPH KIM, Ph.D. CHOSEN AS ONE OF 40 EXCEPTIONAL PROFESSIONALS BY THE PHILADELPHIA BUSINESS JOURNAL
2/10/02 VIRAL GENOMIX'S J. JOSEPH KIM, Ph.D. NAMED CANDIDATE FOR PRESTIGIOUS TECHNOLOGY REVIEW 100
1/16/02 THE KNOWLEDGE FOUNDATION - DRS. WEINER & KIM TO PRESENT AT THE ADVANCES IN DESIGNING CANCER VACCINES
12/16/01 ASM NEWS - DR. WEINER RECEIVES THE PROGRAM COMMITTEE AWARD AT THE 41ST ICAAC
11/26/01 FORBES - BATTLE UNREADY - AGAINST BIOTERRORISM
11/13/01 NATIONAL PRESS CLUB - DR. WEINER TO PRESENT AT BIOETHICS AND BIOTERRORISM CONFERENCE
10/19/01 REUTERS- WEST NILE VACCINE PROMPTS IMMUNITY IN MICE
11/1/99 UNISCI - ONE HIV GENE KILLS ALL TUMORS IN LAB TESTS


 
 
© 2008 VGX™ Pharmaceuticals. All rights reserved.